CEO of Novo Nordisk discusses concerns about medicine access in Europe and the importance of purpose. Topics include obesity, childhood obesity challenges, drug development, corporate cultural differences, and longevity in leadership.

CEOs of Novo Nordisk and AstraZeneca discuss the Sustainable Markets Initiative Health Systems Task Force, decarbonizing the supply chain, and innovation in the pharmaceutical industry towards achieving a net-zero world.